Concentras Parent Revenue 2022-2025 | CON
Concentras Parent revenue from 2022 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Concentras Parent Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $1,900 |
| 2023 | $1,838 |
| 2022 | $1,724 |
| 2021 | $1,732 |
|
Concentras Parent Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $573 |
| 2025-06-30 | $551 |
| 2025-03-31 | $501 |
| 2024-12-31 | $465 |
| 2024-09-30 | $490 |
| 2024-06-30 | $478 |
| 2024-03-31 | $468 |
| 2023-12-31 | |
| 2023-09-30 | $474 |
| 2023-06-30 | $467 |
| 2022-12-31 | |
| 2021-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.479B | $1.900B |
| Concentra Group Holdings Parent Inc. is a provider of occupational health services principally in the United States. Concentra Group Holdings Parent Inc. is based in MECHANICSBURG, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.291B | 27.23 |
| HCA Healthcare (HCA) | United States | $108.759B | 18.01 |
| CVS Health (CVS) | United States | $100.272B | 11.53 |
| Elevance Health (ELV) | United States | $70.623B | 10.36 |
| Cencora (COR) | United States | $69.932B | 22.56 |
| Natera (NTRA) | United States | $27.391B | 0.00 |
| DiDi Global (DIDIY) | China | $25.980B | 21.23 |
| Labcorp Holdings (LH) | United States | $20.950B | 15.98 |
| Medpace Holdings (MEDP) | United States | $16.595B | 41.20 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.557B | 0.00 |
| ICON (ICLR) | Ireland | $12.852B | 12.75 |
| Solventum (SOLV) | United States | $12.405B | 12.04 |
| CochLear (CHEOY) | Australia | $12.093B | 0.00 |
| Viatris (VTRS) | United States | $11.656B | 4.34 |
| Revvity (RVTY) | United States | $10.292B | 18.95 |
| Charles River Laboratories (CRL) | United States | $8.271B | 15.93 |
| HealthEquity (HQY) | United States | $8.074B | 32.31 |
| Avantor (AVTR) | United States | $7.875B | 12.03 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.226B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.746B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.977B | 35.63 |
| Bausch + Lomb (BLCO) | Canada | $5.508B | 36.16 |
| Sotera Health (SHC) | United States | $4.455B | 21.48 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $4.039B | 70.93 |
| Alignment Healthcare (ALHC) | United States | $3.268B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.757B | 34.68 |
| Premier (PINC) | United States | $2.324B | 22.52 |
| Ardent Health (ARDT) | United States | $2.061B | 7.96 |
| Progyny (PGNY) | United States | $1.923B | 37.92 |
| Pediatrix Medical (MD) | United States | $1.883B | 11.25 |
| Establishment Labs Holdings (ESTA) | $1.883B | 0.00 | |
| PACS (PACS) | United States | $1.878B | 0.00 |
| Organon (OGN) | United States | $1.763B | 1.92 |
| Teladoc Health (TDOC) | United States | $1.336B | 0.00 |
| Omada Health (OMDA) | $1.169B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.081B | 17.28 |
| Embecta (EMBC) | United States | $0.807B | 4.72 |
| CareDx (CDNA) | United States | $0.803B | 13.13 |
| InnovAge Holding (INNV) | United States | $0.718B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.685B | 9.45 |
| Nutex Health (NUTX) | United States | $0.637B | 9.64 |
| Sonida Senior Living (SNDA) | United States | $0.604B | 0.00 |
| Pomdoctor - (POM) | China | $0.540B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.523B | 0.00 |
| So-Young (SY) | China | $0.449B | 0.00 |
| CryoPort (CYRX) | United States | $0.420B | 0.00 |
| Enhabit (EHAB) | United States | $0.402B | 18.07 |
| Auna S.A (AUNA) | Luxembourg | $0.401B | 6.02 |
| Charming Medical (MCTA) | $0.374B | 0.00 | |
| Strata Critical Medical (SRTA) | United States | $0.362B | 0.00 |
| KindlyMD (NAKA) | United States | $0.339B | 0.00 |
| Oncology Institute (TOI) | United States | $0.331B | 0.00 |
| SBC Medicals (SBC) | United States | $0.327B | 7.16 |
| Agilon Health (AGL) | United States | $0.277B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.225B | 0.00 |
| Beauty Health (SKIN) | United States | $0.178B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.124B | 0.00 |
| DocGo (DCGO) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.095B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.026B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 5.89 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |